A Pakistani court has sought responses from federal authorities to a petition challenging the amendment of policy to allow the import of medicines and vaccines from India.
A Rawalpindi-based single judge bench of the Lahore High Court issued notices to the federal secretaries of the ministries of health and commerce after a private pharmaceutical company filed a petition against the amendment in policy for trade with India.
The court also issued notices yesterday on a civil application against an earlier stay on the purchase of Indian vaccines as the federal government had revised the trade policy, clearing the way for import of vaccines from the neighbouring country.
The court will take up both matters on December 2. While taking up an application filed by the government, the judge observed that it seemed the stay granted by the court on imports from India had annoyed the administration, which had decided to amend the policy.
In its petition, the pharmaceutical company said the government should be stopped from amending the trade policy as stakeholders had not been taken on board about the changes.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
